There is convincing evidence that PD-L1 promotes HNSCC cell growth through mTOR signaling, further supporting the role of mTOR metabolic signaling in immune evasion in HNSCC (58). The gene discussed is MTOR; the disease is head and neck squamous cell carcinoma.